Scientific article
Editorial
OA Policy
English

Cobicistat : A case of mislabelled drug-drug interaction risk?

Published in

British journal of clinical pharmacology, vol. 86, no. 5, p. 834-836

Publication date

2020-05

First online date

2020-03-06

Keywords

  • HIV/AIDS
  • Cytochrome P450
  • Drug interactions
  • Anti-HIV Agents / pharmacology
  • Cobicistat / pharmacology
  • Darunavir
  • Drug Interactions
  • Drug Labeling
  • HIV Infections / drug therapy
  • Humans
  • Pharmaceutical Preparations

Citation (ISO format)

BURGER, David M, CALMY, Alexandra, MARZOLINI, Catia. Cobicistat : A case of mislabelled drug-drug interaction risk? In: British journal of clinical pharmacology, 2020, vol. 86, n° 5, p. 834–836. doi: 10.1111/bcp.14262

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0306-5251
85views
30downloads

Technical informations

Creation

23/02/2022 14:41:01

First validation

22/11/2023 14:52:15

Update

22/11/2023 14:52:15

Status update

22/11/2023 14:52:15

Last indexation

01/11/2024 06:48:31
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated